Logo image of NAOV

NANOVIBRONIX INC (NAOV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NAOV - US63008J8844 - Common Stock

4.02 USD
-0.29 (-6.73%)
Last: 12/11/2025, 8:00:01 PM
Fundamental Rating

2

NAOV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. NAOV has a bad profitability rating. Also its financial health evaluation is rather negative. NAOV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year NAOV has reported negative net income.
  • NAOV had a negative operating cash flow in the past year.
  • NAOV had negative earnings in each of the past 5 years.
  • NAOV had a negative operating cash flow in each of the past 5 years.
NAOV Yearly Net Income VS EBIT VS OCF VS FCFNAOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M

1.2 Ratios

  • The Return On Assets of NAOV (-10.54%) is better than 60.43% of its industry peers.
  • With a decent Return On Equity value of -13.40%, NAOV is doing good in the industry, outperforming 64.17% of the companies in the same industry.
Industry RankSector Rank
ROA -10.54%
ROE -13.4%
ROIC N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
NAOV Yearly ROA, ROE, ROICNAOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K

1.3 Margins

  • NAOV has a Gross Margin of 32.06%. This is in the lower half of the industry: NAOV underperforms 75.40% of its industry peers.
  • NAOV's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NAOV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
NAOV Yearly Profit, Operating, Gross MarginsNAOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

More info and screens

2

2. Health

2.1 Basic Checks

  • NAOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NAOV has been increased compared to 1 year ago.
  • The number of shares outstanding for NAOV has been increased compared to 5 years ago.
  • NAOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NAOV Yearly Shares OutstandingNAOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10K 20K 30K
NAOV Yearly Total Debt VS Total AssetsNAOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • NAOV has an Altman-Z score of -2.30. This is a bad value and indicates that NAOV is not financially healthy and even has some risk of bankruptcy.
  • NAOV's Altman-Z score of -2.30 is on the low side compared to the rest of the industry. NAOV is outperformed by 63.10% of its industry peers.
  • NAOV has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • NAOV's Debt to Equity ratio of 0.05 is fine compared to the rest of the industry. NAOV outperforms 68.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -2.3
ROIC/WACCN/A
WACC8.8%
NAOV Yearly LT Debt VS Equity VS FCFNAOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

2.3 Liquidity

  • NAOV has a Current Ratio of 1.05. This is a normal value and indicates that NAOV is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.05, NAOV is not doing good in the industry: 88.24% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.72 indicates that NAOV may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.72, NAOV is not doing good in the industry: 87.17% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.72
NAOV Yearly Current Assets VS Current LiabilitesNAOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

3

3. Growth

3.1 Past

  • NAOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.01%, which is quite impressive.
  • Looking at the last year, NAOV shows a very negative growth in Revenue. The Revenue has decreased by -18.41% in the last year.
  • NAOV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.00% yearly.
EPS 1Y (TTM)39.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAOV Yearly Revenue VS EstimatesNAOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
NAOV Yearly EPS VS EstimatesNAOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2018 -200 -400 -600 -800 -1K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NAOV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAOV Price Earnings VS Forward Price EarningsNAOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NAOV Per share dataNAOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40 -60 -80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • NAOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NANOVIBRONIX INC

NASDAQ:NAOV (12/11/2025, 8:00:01 PM)

4.02

-0.29 (-6.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14
Earnings (Next)03-30
Inst Owners0.54%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap4.38M
Revenue(TTM)2.69M
Net Income(TTM)-5.42M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.87
P/FCF N/A
P/OCF N/A
P/B 0.11
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-83.93
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.61
FCFYN/A
OCF(TTM)-5.61
OCFYN/A
SpS2.15
BVpS37.13
TBVpS-3.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.54%
ROE -13.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.07%
FCFM N/A
ROA(3y)-83.46%
ROA(5y)-93.73%
ROE(3y)-284.23%
ROE(5y)-252.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.18%
GM growth 5Y2.22%
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.36%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.72
Altman-Z -2.3
F-Score2
WACC8.8%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.41%
Revenue growth 3Y14.59%
Revenue growth 5Y37%
Sales Q2Q%92.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-212.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.63%
OCF growth 3YN/A
OCF growth 5YN/A

NANOVIBRONIX INC / NAOV FAQ

What is the ChartMill fundamental rating of NANOVIBRONIX INC (NAOV) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NAOV.


Can you provide the valuation status for NANOVIBRONIX INC?

ChartMill assigns a valuation rating of 0 / 10 to NANOVIBRONIX INC (NAOV). This can be considered as Overvalued.


Can you provide the profitability details for NANOVIBRONIX INC?

NANOVIBRONIX INC (NAOV) has a profitability rating of 2 / 10.